Monday, 11 July 2022

Lupin Somerset Manufacturing Plant Receives EIR from USFDA

Lupin Somerset Manufacturing Plant Receives EIR from USFDA
Lupin Somerset Manufacturing Plant Receives EIR from US FDA

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

admin Mon, 07/11/2022 - 15:16

source https://www.pharmatutor.org/pharma-news/2022/lupin-somerset-manufacturing-plant-receives-eir-from-us-fda

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...